Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Surgical Oncology|June 3, 2015
The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ resultMichael Alvarado, Dennis L Carter, J Michael Guenther, et al.
American Journal of Surgery|November 21, 2024
Balancing risks of surgical complications and positive margins for patients with invasive lobular carcinoma of the breast and elevated BMI: An institutional cohort studyIsrael Falade, Kayla Switalla, Astrid Quirarte, et al.
Annals of Surgical Oncology|June 4, 2020
Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced MelanomaLauren S Levine, Kelly M Mahuron, Katy K Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast CancerMark Jesus M Magbanua, Christina Yau, Denise M Wolf, et al.
Cancer Cytopathology|October 9, 2025
FNA biopsy of breast specimens effectively harvests cells for patient-derived organoids modeling ductal carcinoma in situJulia Ye, Nadine Goldhammer, Poonam Vohra, et al.
Cancer Research|March 5, 2025
Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in MelanomaKelly M Mahuron, Osmaan Shahid, Prachi Sao, et al.
Lancet (London, England)|June 24, 2010
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trialJayant S Vaidya, David J Joseph, Jeffrey S Tobias, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2025
Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Based on 10-Year Ipsilateral Breast Recurrence RatesFrank Vicini, Chirag Shah, Karuna Mittal, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissueNadine Goldhammer, Marin Bont, Shruti Warhadpande, et al.
Lancet (London, England)|November 15, 2013
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trialJayant S Vaidya, Frederik Wenz, Max Bulsara, et al.
Pageof 6